IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment

Meiqi Duan; Haiyang Liu; Shasha Xu; Zhi Yang; Fusheng Zhang; Guang Wang; Yutian Wang; Shan Zhao; Xiaofeng Jiang

doi:10.1016/j.gendis.2023.06.017

您当前的位置：

首页 >

文章列表页 >

IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment

Review article | 更新时间：2024-02-04

- IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment
- IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment
- Genes & Diseases 2024年11卷第2期
- 作者机构：
  
  1. Department of General Surgery, The Fourth Affiliated Hospital of China Medical University,Liaoning,Shenyang,China,110032
  2. Department of Rheumatology and Immunology, The First Affiliated Hospital of China Medical University,Liaoning,Shenyang,China,110002
  3. Department of Gastroendoscopy, The Fourth Affiliated Hospital of China Medical University,Liaoning,Shenyang,China,110032
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.06.017
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-3-1，
扫描看全文
Meiqi Duan, Haiyang Liu, Shasha Xu, 等. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment[J]. Genes & Diseases, 2024,11(2).

Meiqi Duan, Haiyang Liu, Shasha Xu, et al. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment[J]. Genes & Diseases, 2024,11(2).
Meiqi Duan, Haiyang Liu, Shasha Xu, 等. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment[J]. Genes & Diseases, 2024,11(2). DOI： 10.1016/j.gendis.2023.06.017.

Meiqi Duan, Haiyang Liu, Shasha Xu, et al. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment[J]. Genes & Diseases, 2024,11(2). DOI： 10.1016/j.gendis.2023.06.017.

摘要

Abstract

A methylation is the most frequent modification of mRNA in eukaryotes and plays a crucial role in cancer progression by regulating biological functions. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BP) are newly identified m

A ‘readers’. They belong to a family of RNA-binding proteins

which bind to the m

A sites on different RNA sequences and stabilize them to promote cancer progression. In this review

we summarize the mechanisms by which different upstream factors regulate IGF2BP in cancer. The current literature analyzed here reveals that the IGF2BP family proteins promote cancer cell proliferation

survival

and chemoresistance

inhibit apoptosis

and are also associated with cancer glycolysis

angiogenesis

and the immune response in the tumor microenvironment. Therefore

with the discovery of their role as ‘readers’ of m

A and the characteristic re-expression of IGF2BPs in cancers

it is important to elucidate their mechanism of action in the immunosuppressive tumor microenvironment. We also describe in detail the regulatory and interaction network of the IGF2BP family in downstream target RNAs and discuss their potential clinical applications as diagnostic and prognostic markers

as well as recent advances in IGF2BP biology and associated therapeutic value.

关键词

Keywords

CancerIGF2BPImmunosuppressive TMEm6AMolecular mechanismTherapy

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer

DEAD-box RNA helicases with special reference to p68: Unwinding their biology, versatility, and therapeutic opportunity in cancer

CCL5/CCR5 axis in human diseases and related treatments

The paradoxical functions of long noncoding RNAs in hepatocellular carcinoma: Implications in therapeutic opportunities and precision medicine

De novo nucleotide biosynthetic pathway and cancer